Open AccessVecabrutinib inhibits B-cell receptor signal transduction in chronic lymphocytic leukemia cell types with wild-type or mutant Bruton tyrosine kinase
Author(s) -
Burcu Aslan,
Stefan Hübner,
Judith A. Fox,
Pietro Taverna,
William G. Wierda,
Steven M. Kornblau,
Varsha Gandhi
Publication year - 2021
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2021.279158
Subject(s) - bruton's tyrosine kinase , chronic lymphocytic leukemia , signal transduction , mutant , ror1 , cancer research , tyrosine kinase , receptor tyrosine kinase , receptor , biology , leukemia , microbiology and biotechnology , chemistry , immunology , platelet derived growth factor receptor , genetics , gene , growth factor